Peer Review History
| Original SubmissionOctober 10, 2023 |
|---|
|
PONE-D-23-32654Primary care quality for older adults: practice-based quality measures derived from a RAND/UCLA appropriateness method studyPLOS ONE Dear Dr. Correia, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Based on the reviewers' feedback, which includes three different decisions, I kindly request that you consider making significant revisions to your work. I want to be transparent and inform you that if any of the reviewers reject your revised version, I will promptly reject it as well. Please submit your revised manuscript by Dec 24 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohammad Sadegh Taghizadeh Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your list of authors on the manuscript to ensure that each author is linked to an affiliation. Authors’ affiliations should reflect the institution where the work was done (if authors moved subsequently, you can also list the new affiliation stating “current affiliation:….” as necessary). [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is generally a well-written manuscript with general concern as immediately below ("line 57 and generally") towards suitability for review and publication in PLOS ONE. Other edits are thereafter detailed. --line 57 and generally: since this is an effort to define practice-based quality measures for geriatric care (through consensus of a technical expert panel), I think this would be best reviewed and considered by a geriatric and/or primary care journal, perhaps even a Canada-specific journal (Canadian Family Physician?) given the potential lack of generalizability across health service systems and consensus of only 10 individuals from a relatively limited geographic area (is this "technically sound"?). or even BMJ Open where the protocol paper was published? --line 43, lines 306-307: em dashes should be here without spaces --line 71: why an informal literature search vs. systematic or scoping review? --table 1: I understand “inclusive but not necessarily exclusive” but this statement may benefit from more straightforward wording? “must be related to the care of older adults but not necessarily limited to the care of older adults only”? --line 201: since scores were skewed, can scores be presented as a scatter plot with a line at 35% to clearly see the raw score difference for the top 19 vs. other items? table 2: --item 2: a new medication for what? --item 4: what is dementia care management? --are items 2 and 3 not included in item 5? --is item 6 not included in item 4? this seems specific to Canada? --why are the items listed in this order? item 8 seems to logically come before item 4? --the differences between item 9 and items 1 and 10 seem minimal… --item 11: understand perhaps hard to “measure” (and acknowledged lines 321-322) but for safe clinical interpretation, feel the following clarifications are necessary — ACE/ARB/ARNI to clarify (patients shouldn’t be more than one of these), an appropriate beta-blocker (carvedilol, long-acting metoprolol, or bisoprolol), and SGLT2 inhibitor, all pending clinical appropriateness and renal function (i.e., will have to be more carefully considered or avoided with allergies, advanced renal disease, and/or hypotension) --item 12: is this not included in item 4? --again, why are items listed in this order? would personally prefer some grouping (e.g., vaccines, dementia, medication management) --line 296: we does not need capitalized --line 311: measurement does not need capitalized --lines 317-319: this sentence seems mis-edited? established or endorsed that define primary care quality? --line 322: rather does not need capitalized --line 336: future does not need capitalized --lines 344-345: I understand these as practical limitation. almost everything is limited by time and resources but this is not a justification to publish incomplete science. stating it here is not necessary and detracts from the meaningful work that is otherwise presented. --line 348: rather does not need capitlized --line 350: these does not need capitalized Reviewer #2: The purpose of the study is to establish consensus on practice-based metrics that characterize quality of community-based primary healthcare for older primary care patients. The quality indicators should be accessible using health administrative data. There is a need for patient-centered appropriate and important quality indicators. The current project basis its methods on the RAND/UCAL Appropriateness Methods (RAM). Referred to as an established methods. it was adopted to fit in terms of establishing indicators for older patients. Apart from establishing a set of quality indicators, the paper also present data on the technical definitions of the respective quality domains assessed. Abstract The abstract is comprehensive and appropriately reflects the study design and findings. Introduction The introduction covers rel3evant areas and references. Major challenges to using administrative data include difficulty getting access to relevant/sought after data. Much adm data is gathered for billing and monitoring productivity. The manuscript discusses the need to select indicators for which administrative data is available. However, the manuscript should recognize, and discuss, in the intro the challenges of using administrative data, the need to have provider buy-ins, that these identifiers reflect quality of care. Moreover, the manuscript should refer to other large administrative databases that exist in terms of assessing healthcare provisions for elderly persons. For example, in the US Health grade. The introduction largely fails to review the pros and cons of using administrative data only without engaging the patient perspective. Methods State 2 is well described. it is a strength that Priority Topics and Key Features for assessment of Competence in Care of Elderly (FM-COE Priority Topics were used to organize quality indicators. Stage 2What was the response/acceptance rate? That is, out of xx providers approached, how many accepted. Stage 3 Clarify line 108. If th median score was betwen 7 and 9, how could an extreme rating be defined as (i.e. xx or 7-9)? Developing Technical Definition: what is the dealy between clinical/adm data is collected and processed, and assessible in ICES? How reevant are proposed datasets to determine quality indicators in real-life - limiting the delay in feedback as to make data relevant for QI efforts in the clinic? Synchronous panel meeting: Did the second meeting, when experts reviewed and scored proposed quality indicators also done virtually in a panel format? Results Fig 1. Expand in text what the figure is supposed to represent - what is the conclusion? Fig 2, similar to above, expand the explanatory text in the manuscript. Technical panel, line 190 and ff. Move descriptive part to Methods, where Provider characteristics are presented. Consider reducing number of tables/figures. Discussion Statement that consensus was established - line 292. Provide data support for the statement. Moreover, discuss relatively low median scores for both Appropriateness and Importance (5-7). Sounds like these quality indicators are not rated very high by neither providers, nor technical experts in terms of Appropriateness and Importance. The manuscript contains a substantial amount of data, specifically in a rather large number of attachments. This data is only limited referred to in the result section. moreover, even less discussed in the discussion section. Rather, generic comments are provided, e. g., line 307 and 308: "-were concentrated on biomedical aspects of caring for elderly patients - namely, the "Medical Conditions". This is well known, lack of functional quality indicators, survival data, and patient-perspectives are major limitations in current quality of care indicator data. as in this article, much data is process rather than outcome focused. The Discussion section is very limited, does not refer to the greater debate of relevance, and hardly et al refer to other studies of relevance. Furthermore, the authors should discuss the relevance of using only expert-derived quality indicators in an age of patient-centered primary care. Lack of including patients or caregivers are briefly touched on in Limitation (ll 340-343. However, referring to another study to be, does not address this major shortcomings. Even when exploring how to use administrative data. such data can be generated for patients and caretakers as well. Reviewer #3: thank you for reviewing this interesting paper. The study is well conducted and provides an interesting view on how to characterize quality of care for older primary care patients on population level. Some questions and minor comments could enhance the readability of the paper. Introduction
Methods
Results
Discussion
6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Bengt B. Arnetz, MD, PhD Reviewer #3: Yes: dr. Nienke Bleijenberg ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-23-32654R1Primary care quality for older adults: practice-based quality measures derived from a RAND/UCLA appropriateness method studyPLOS ONE Dear Dr. Correia, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Mohammad Sadegh Taghizadeh Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This revision is improved, notably from a more robust discussion of limitations and methodological focus. The authors responded well to all reviewer comments. There are remaining points/questions as below. -Line 28: I wouldn't say pan-Canadian. 9 were based in Ontario. Perhaps just Canadian -Line 78: Donabedian model should be defined here (in the author's own words) -Line 259: to do what? -Table 2: --why not have 1 and 4 (vaccines) next to each other? --2 and 12 can both go under cognitive impairment, yes? --why are rows from Medical Conditions shaded and most rows from Appropriate prescribing shaded (and the others not)? -Line 353: comma after available -Line 384: "pragmatic reasons" is the predetermined two-hour panel meeting length, yes? If so, I would specify that to acknowledge it as a limitation "pragmatic reasons (i.e., the predetermined two-hour panel meeting length)" -Figures (Figure 1, S1-2, and scatter plot figures as below) should have figure legends. Supplementary Figure 2: --x-axis: round instead of group, yes? --perhaps a more meaningful title than response_bias_score? Isn't this the "Wilcoxon matched-pairs signed-rank test for consensus scores"? --including n number for each round would be nice and clear --how did the Pr > Z scores translate to the p-value? wouldn't these be the same? -Supplementary Table 6: This title needs changed, correct? Items in the "Presented in panel group meeting" and "Rated in questionnaire 2" columns were prioritized in round 2, correct? The table should also be referenced accordingly in the results section, not just at the end of the discussion -While I acknowledge Reviewer #2's comment to reduce the number of tables/figures, I believe they are all meaningful in this revision and describe important study components. I feel the additional scatter plot figure in response to Reviewer #1 provides meaningful context to Figure 1 and Supplementary Table 6 and should be included in this submission (and would also be more "outcome focused" aligning with Reviewer #2's comments). With this though, I don't see where it was mentioned in the manuscript where 14 indicators had equal summed scores and had to be sequenced by lowest IQR. A similar scatter plot with IQR on the Y axis should thus also be included (perhaps part of the same figure as the summed median score scatter plot) for these 14 items to clearly see the raw IQR difference between the 5 included vs. other items. Were they sequenced based on summed IQR (Appropriateness + Importance)? This should be included as a result and limitation. -I do agree with Reviewer #3 that "operationalize" is not explicitly described. I interpret it to mean able to be examined data-wise, but I could also (I believe mis-)interpret it to mean directly used to clinical care. Can "operationalize" be described in the introduction? perhaps with the Donabedian model? or changed to "examine" if appropriate? Reviewer #2: The authors have addressed my concerns. In the few cases they have not, they have provided a good rationale for not doing so. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Bengt B. Arnetz ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Primary care quality for older adults: practice-based quality measures derived from a RAND/UCLA appropriateness method study PONE-D-23-32654R2 Dear Dr. Correia, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Specifically, please apply the reviewer's comments in the proof version. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohammad Sadegh Taghizadeh Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have responded to all reviewer suggestions in a very thoughtful, generally thorough, and timely fashion. A few small editorial points as below, but I believe this article is now scientifically fine to be accepted pending statistical review (specifically confirming that the Figure S3 Pr > |Z| value of 0.1303 aligns with the p value of 0.0391 reported on line 304 of this submission).. --lines 80-81: The Donabedian model is acceptably characterized but not optimally defined here. Perhaps "Along with clinical structures and medical outcomes, healthcare service delivery processes are one of three interrelated components..." --lines 306-309: Figure 1 legend will need reformatted as it is currently included in the text rather than at the end of the manuscript with the other figure legends.. --lines 374-375: is this meant to read "quality primary care quality"? --line 411: is this meant to read "the context population-based" or "the context of population-based"? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-23-32654R2 PLOS ONE Dear Dr. Correia, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mohammad Sadegh Taghizadeh Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .